{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:36:30Z","timestamp":1776303390841,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97753-2","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T15:07:27Z","timestamp":1745075247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Structure-guided screening identified bioactive phytoconstituents Hernandonine and Anolobine as potential inhibitors of dual specificity protein kinase CLK1"],"prefix":"10.1038","volume":"15","author":[{"given":"Sumaiya","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunabh","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taj","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Shamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asimul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"97753_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson, D. M. et al. Hallmarks of neurodegenerative diseases. Cell 186, 693\u2013714 (2023).","journal-title":"Cell"},{"key":"97753_CR2","doi-asserted-by":"crossref","unstructured":"Association, A. Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s & Dementia 14, 367\u2013429 (2018). (2018).","DOI":"10.1016\/j.jalz.2018.02.001"},{"key":"97753_CR3","doi-asserted-by":"crossref","unstructured":"Nandi, A. et al. Global and regional projections of the economic burden of Alzheimer\u2019s disease and related dementias from 2019 to 2050: A value of statistical life approach. EClinicalMedicine 51, 101580 (2022).","DOI":"10.1016\/j.eclinm.2022.101580"},{"key":"97753_CR4","first-page":"708","volume":"16","author":"L Sequeira","year":"2024","unstructured":"Sequeira, L. et al. Drug development for Alzheimer\u2019s and Parkinson\u2019s disease. Where Do We Go Now? Pharm. 16, 708 (2024).","journal-title":"Where Do We Go Now? Pharm."},{"key":"97753_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3389\/fpsyt.2020.00699","volume":"11","author":"Y Eisenmann","year":"2020","unstructured":"Eisenmann, Y., Golla, H., Schmidt, H., Voltz, R. & Perrar, K. M. Palliative care in advanced dementia. Front. Psychiatry. 11, 699 (2020).","journal-title":"Front. Psychiatry"},{"key":"97753_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/156802606776743057","volume":"6","author":"I Churcher","year":"2006","unstructured":"Churcher, I. Tau therapeutic strategies for the treatment of Alzheimer\u2019s disease. Curr. Top. Med. Chem. 6, 579\u2013595 (2006).","journal-title":"Curr. Top. Med. Chem."},{"key":"97753_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ijbiomac.2019.04.120","volume":"133","author":"A Venkatramani","year":"2019","unstructured":"Venkatramani, A. & Panda, D. Regulation of neuronal microtubule dynamics by Tau: implications for tauopathies. Int. J. Biol. Macromol. 133, 473\u2013483 (2019).","journal-title":"Int. J. Biol. Macromol."},{"key":"97753_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2174\/1389450115666140226112321","volume":"15","author":"P Jain","year":"2014","unstructured":"Jain, P. et al. Human CDC2-like kinase 1 (CLK1): A novel target for Alzheimer\u2019s disease. Curr. Drug Targets. 15, 539\u2013550 (2014).","journal-title":"Curr. Drug Targets"},{"key":"97753_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/med.21928","volume":"43","author":"AK ElHady","year":"2023","unstructured":"ElHady, A. K., El-Gamil, D. S., Abadi, A. H., Abdel\u2010Halim, M. & Engel, M. An overview of cdc2\u2010like kinase 1 (Clk1) inhibitors and their therapeutic indications. Med. Res. Rev. 43, 343\u2013398 (2023).","journal-title":"Med. Res. Rev."},{"key":"97753_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1083\/jcb.201107093","volume":"195","author":"K Ninomiya","year":"2011","unstructured":"Ninomiya, K., Kataoka, N. & Hagiwara, M. Stress-responsive maturation of Clk1\/4 pre-mRNAs promotes phosphorylation of SR splicing factor. J. Cell Biol. 195, 27 (2011).","journal-title":"J. Cell Biol."},{"key":"97753_CR11","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1242\/jcs.113.18.3241","volume":"113","author":"HJ Menegay","year":"2000","unstructured":"Menegay, H. J., Myers, M. P., Moeslein, F. M. & Landreth, G. E. Biochemical characterization and localization of the dual specificity kinase CLK1. J. Cell Sci. 113, 3241\u20133253 (2000).","journal-title":"J. Cell Sci."},{"key":"97753_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.molcel.2016.05.034","volume":"63","author":"BE Aubol","year":"2016","unstructured":"Aubol, B. E. et al. Release of SR proteins from CLK1 by SRPK1: a symbiotic kinase system for phosphorylation control of pre-mRNA splicing. Mol. Cell. 63, 218\u2013228 (2016).","journal-title":"Mol. Cell"},{"key":"97753_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41392-023-01409-4","volume":"8","author":"M Song","year":"2023","unstructured":"Song, M. et al. Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases. Signal. Transduct. Target. Therapy. 8, 148 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"97753_CR14","doi-asserted-by":"crossref","unstructured":"Ansari, M. M., Sahu, S. K., Singh, T. G., Singh, S. & Kaur, P. Evolving significance of kinase inhibitors in the management of Alzheimer\u2019s disease. Eur. J. Pharmacol., 979, 176816 (2024).","DOI":"10.1016\/j.ejphar.2024.176816"},{"key":"97753_CR15","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1021\/acs.jmedchem.1c00980","volume":"65","author":"RA Serafim","year":"2021","unstructured":"Serafim, R. A., Elkins, J. M., Zuercher, W. J., Laufer, S. A. & Gehringer, M. Chemical probes for understudied kinases: challenges and opportunities. J. Med. Chem. 65, 1132\u20131170 (2021).","journal-title":"J. Med. Chem."},{"key":"97753_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","volume":"616","author":"AV Sadybekov","year":"2023","unstructured":"Sadybekov, A. V. & Katritch, V. Computational approaches streamlining drug discovery. Nature 616, 673\u2013685 (2023).","journal-title":"Nature"},{"key":"97753_CR17","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3390\/ijms20112783","volume":"20","author":"M Batool","year":"2019","unstructured":"Batool, M., Ahmad, B. & Choi, S. A structure-based drug discovery paradigm. Int. J. Mol. Sci. 20, 2783 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"97753_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3390\/molecules25040823","volume":"25","author":"T Mohammad","year":"2020","unstructured":"Mohammad, T. et al. Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: combined molecular Docking and simulation studies. Molecules 25, 823 (2020).","journal-title":"Molecules"},{"key":"97753_CR19","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1080\/07391102.2019.1682052","volume":"38","author":"M Amir","year":"2020","unstructured":"Amir, M. et al. Virtual high-throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1). J. Biomol. Struct. Dynamics. 38, 4625\u20134634 (2020).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"97753_CR20","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","volume":"24","author":"LL Ferreira","year":"2019","unstructured":"Ferreira, L. L. & Andricopulo, A. D. ADMET modeling approaches in drug discovery. Drug Discovery Today. 24, 1157\u20131165 (2019).","journal-title":"Drug Discovery Today"},{"key":"97753_CR21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1089\/omi.2021.0107","volume":"25","author":"F Anjum","year":"2021","unstructured":"Anjum, F. et al. Phytoconstituents and medicinal plants for anticancer drug discovery: computational identification of potent inhibitors of PIM1 kinase. Omics: J. Integr. Biology. 25, 580\u2013590 (2021).","journal-title":"Omics: J. Integr. Biology"},{"key":"97753_CR22","doi-asserted-by":"crossref","unstructured":"Choudhary, S. et al. Potential uses of bioactive compounds of medicinal plants and their mode of action in several human diseases. Med. Aromatic Plants: Healthc. Industrial Appl., 143\u2013158 (2021).","DOI":"10.1007\/978-3-030-58975-2_5"},{"key":"97753_CR23","doi-asserted-by":"crossref","unstructured":"Patra, S., Pradhan, B., Nayak, R., Behera, C., Rout, L., Jena, M., Efferth, T. and Bhutia, S.K. Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics. in Semin Cancer Biol. 73, 310\u2013320 (2021) Academic Press.","DOI":"10.1016\/j.semcancer.2020.10.010"},{"key":"97753_CR24","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.2174\/1568026621666211201150217","volume":"21","author":"DK Yadav","year":"2021","unstructured":"Yadav, D. K. Potential therapeutic strategies of phytochemicals in neurodegenerative disorders. Curr. Top. Med. Chem. 21, 2814\u20132838 (2021).","journal-title":"Curr. Top. Med. Chem."},{"key":"97753_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0973-7847.99898","volume":"6","author":"GP Kumar","year":"2012","unstructured":"Kumar, G. P. & Khanum, F. Neuroprotective potential of phytochemicals. Pharmacogn. Rev. 6, 81 (2012).","journal-title":"Pharmacogn. Rev."},{"key":"97753_CR26","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1080\/07391102.2022.2154849","volume":"41","author":"MI Hassan","year":"2023","unstructured":"Hassan, M. I. et al. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy. J. Biomol. Struct. Dynamics. 41, 10558\u201310568 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"97753_CR27","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","volume":"8","author":"R Vivek-Ananth","year":"2023","unstructured":"Vivek-Ananth, R., Mohanraj, K., Sahoo, A. K. & Samal, A. IMPPAT 2.0: an enhanced and expanded phytochemical atlas of Indian medicinal plants. ACS Omega. 8, 8827\u20138845 (2023).","journal-title":"ACS Omega"},{"key":"97753_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski, C. A. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technol. 1, 337\u2013341 (2004).","journal-title":"Drug Discovery Today: Technol."},{"key":"97753_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/acs.jnatprod.5b00947","volume":"79","author":"JB Baell","year":"2016","unstructured":"Baell, J. B. Feeling Nature\u2019s PAINS: natural products, natural product drugs, and Pan assay interference compounds (PAINS). J. Nat. Prod. 79, 616\u2013628 (2016).","journal-title":"J. Nat. Prod."},{"key":"97753_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","volume":"50","author":"D Filimonov","year":"2014","unstructured":"Filimonov, D. et al. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem. Heterocycl. Compd. 50, 444\u2013457 (2014).","journal-title":"Chem. Heterocycl. Compd."},{"key":"97753_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1089\/omi.2021.0059","volume":"25","author":"F Anjum","year":"2021","unstructured":"Anjum, F. et al. Discovery of natural compounds as potential inhibitors of human carbonic anhydrase II: an integrated virtual screening, docking, and molecular dynamics simulation study. OMICS: J. Integr. Biology. 25, 513\u2013524 (2021).","journal-title":"OMICS: J. Integr. Biology"},{"key":"97753_CR32","doi-asserted-by":"publisher","first-page":"bbaa279","DOI":"10.1093\/bib\/bbaa279","volume":"22","author":"T Mohammad","year":"2021","unstructured":"Mohammad, T., Mathur, Y., Hassan, M. I. & InstaDock A single-click graphical user interface for molecular docking-based virtual high-throughput screening. Brief. Bioinform. 22, bbaa279 (2021).","journal-title":"Brief. Bioinform."},{"key":"97753_CR33","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano, W. L. & Pymol An open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40, 82\u201392 (2002).","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"key":"97753_CR34","unstructured":"Visualizer, D. Discovery Studio Visualizer. 2. Accelrys software inc (2005)."},{"key":"97753_CR35","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput. Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"key":"97753_CR36","doi-asserted-by":"publisher","first-page":"105742","DOI":"10.1016\/j.pep.2020.105742","volume":"176","author":"N Dekel","year":"2020","unstructured":"Dekel, N. et al. Expression, purification and crystallization of CLK1 kinase\u2013A potential target for antiviral therapy. Protein Exp. Purif. 176, 105742 (2020).","journal-title":"Protein Exp. Purif."},{"key":"97753_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/newbio233223b0","volume":"233","author":"PD Bank","year":"1971","unstructured":"Bank, P. D. Protein data bank. Nat. New. Biol. 233, 223 (1971).","journal-title":"Nat. New. Biol."},{"key":"97753_CR38","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. PkCSM: predicting small-molecule Pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"97753_CR39","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1038\/s41598-017-02365-0","volume":"7","author":"L Zhang","year":"2017","unstructured":"Zhang, L. et al. CarcinoPred-EL: novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods. Sci. Rep. 7, 2118 (2017).","journal-title":"Sci. Rep."},{"key":"97753_CR40","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"U Consortium","year":"2019","unstructured":"Consortium, U. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506\u2013D515 (2019).","journal-title":"Nucleic Acids Res."},{"key":"97753_CR41","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"97753_CR42","first-page":"73","volume":"2","author":"F Neese","year":"2012","unstructured":"Neese, F. The ORCA program system. Wiley Interdisciplinary Reviews: Comput. Mol. Sci. 2, 73\u201378 (2012).","journal-title":"Wiley Interdisciplinary Reviews: Comput. Mol. Sci."},{"key":"97753_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell, M. D. et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 4, 1\u201317 (2012).","journal-title":"J. Cheminform."},{"key":"97753_CR44","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","volume":"27","author":"E Papaleo","year":"2009","unstructured":"Papaleo, E., Mereghetti, P., Fantucci, P., Grandori, R. & De Gioia, L. Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case. J. Mol. Graph. Model. 27, 889\u2013899 (2009).","journal-title":"J. Mol. Graph. Model."},{"key":"97753_CR45","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1080\/07391102.2022.2140200","volume":"41","author":"A Mushtaq","year":"2023","unstructured":"Mushtaq, A. et al. Unravelling hub genes as potential therapeutic targets in lung cancer using integrated transcriptomic meta-analysis and in Silico approach. J. Biomol. Struct. Dynamics. 41, 9089\u20139102 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"97753_CR46","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1080\/07391102.2018.1468282","volume":"37","author":"T Mohammad","year":"2019","unstructured":"Mohammad, T. et al. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4). J. Biomol. Struct. Dynamics. 37, 1813\u20131829 (2019).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"97753_CR47","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2174\/1568026618666181025114157","volume":"18","author":"AA Naqvi","year":"2018","unstructured":"Naqvi, A. A., Mohammad, T., Hasan, G. M. & Hassan, M. I. Advancements in Docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Curr. Top. Med. Chem. 18, 1755\u20131768 (2018).","journal-title":"Curr. Top. Med. Chem."},{"key":"97753_CR48","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ijbiomac.2019.06.158","volume":"136","author":"R Dahiya","year":"2019","unstructured":"Dahiya, R. et al. Investigation of inhibitory potential of Quercetin to the pyruvate dehydrogenase kinase 3: towards implications in anticancer therapy. Int. J. Biol. Macromol. 136, 1076\u20131085 (2019).","journal-title":"Int. J. Biol. Macromol."},{"key":"97753_CR49","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/pharmaceutics13122157","volume":"13","author":"A Shafie","year":"2021","unstructured":"Shafie, A. et al. Identification of phytoconstituents as potent inhibitors of casein kinase-1 alpha using virtual screening and molecular dynamics simulations. Pharmaceutics 13, 2157 (2021).","journal-title":"Pharmaceutics"},{"key":"97753_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov, M. Y., Bogatyreva, N. & Galzitskaya, O. Radius of gyration as an indicator of protein structure compactness. Mol. Biol. 42, 623\u2013628 (2008).","journal-title":"Mol. Biol."},{"key":"97753_CR51","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00894-009-0454-9","volume":"15","author":"E Durham","year":"2009","unstructured":"Durham, E., Dorr, B., Woetzel, N., Staritzbichler, R. & Meiler, J. Solvent accessible surface area approximations for rapid and accurate protein structure prediction. J. Mol. Model. 15, 1093\u20131108 (2009).","journal-title":"J. Mol. Model."},{"key":"97753_CR52","doi-asserted-by":"crossref","unstructured":"Hubbard, R. E. & Haider, M. K. Hydrogen bonds in proteins: role and strength. eLS (2010).","DOI":"10.1002\/9780470015902.a0003011.pub2"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97753-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97753-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97753-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T16:02:23Z","timestamp":1745078543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97753-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97753"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97753-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13604"}}